• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET衍生参数在子宫内膜癌术前分期中的预后作用

Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer.

作者信息

Mapelli P, Bergamini A, Fallanca F, Rancoita P M V, Cioffi R, Incerti E, Rabaiotti E, Petrone M, Mangili G, Candiani M, Gianolli L, Picchio M

机构信息

Vita-Salute San Raffaele University, Milan, Italy; Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Unit of Obstetrics and Gynaecology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Jan-Feb;38(1):3-9. doi: 10.1016/j.remn.2018.06.007. Epub 2018 Dec 17.

DOI:10.1016/j.remn.2018.06.007
PMID:30573387
Abstract

PURPOSE

To investigate the preoperative prognostic role of F-FDG PET/CT in patients with endometrial carcinoma (EC).

METHODS

F-FDG PET/CT was performed in 57 patients for EC preoperative staging. Maximum and mean standardized uptake values (SUVmax, mean), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) of primary tumors, at different thresholds of 40%, 50%, 60% (40-50-60), were evaluated and compared with anatomopathological features. The diagnostic performance of PET-parameters (categorized by ROC analysis) in discriminating low-intermediate and high-risk disease and the prognostic role on survival (overall survival -OS; disease free survival - DFS) was evaluated.

RESULTS

The categorized TLG40-50-60 were the only parameters related to FIGO stage I versus II-III-IV (p = 0.0035 for all). The cut-off values for risk stratification were 83.69, 61.81 and 41.32, respectively (sensitivity: 60.00%; specificity; 71.43% for all parameters). Pathological stage 1 (pT1) of the primary tumor was predicted by MTV60 and TLG40-50 (p = 0.0328, 0.0240, 0.0147, respectively). The optimal thresholds were 7.795, 99.55 and 77.58, respectively (sensitivity: 38.46%, 53.85% and 53.85%, respectively; specificity: 88.64%, 79.55% and 81.82%, respectively). SUVmax and SUVmean40-50-60 were the only parameters discriminating endometrioid from non-endometrioid subtype. The corresponding sensitivity was 64.86% and 62.16% for SUVmax and SUVmean 50-60 and 62.16% for SUVmean40; specificity was 70.00% for all parameters. The mean (SD) OS was 79.77% (3.34%) and the mean DFS was 77.89% (3.73%). The tumor type was the only variable significantly associated with OS (p = 0.0486). TLG50 > 77.58 cm was the only variable associated with a higher risk of relapse (p = 0.0472).

CONCLUSION

TLG40-50-60 and MTV60 of primary EC have prognostic value in discriminating FIGO and pathological staging. These results suggest a possible role of these parameters in predicting EC aggressiveness, thus improving the preoperative characterization of endometrial cancer.

摘要

目的

探讨F-FDG PET/CT在子宫内膜癌(EC)患者术前的预后评估作用。

方法

对57例EC患者进行F-FDG PET/CT检查以进行术前分期。评估原发肿瘤在40%、50%、60%(40-50-60)不同阈值下的最大和平均标准化摄取值(SUVmax、均值)、代谢肿瘤体积(MTV)和总病变糖酵解(TLG),并与解剖病理学特征进行比较。评估PET参数(通过ROC分析分类)在区分低-中危和高危疾病中的诊断性能以及对生存(总生存-OS;无病生存-DFS)的预后作用。

结果

分类后的TLG40-50-60是唯一与FIGO I期与II-III-IV期相关的参数(所有参数p = 0.0035)。风险分层的临界值分别为83.69、61.81和41.32(所有参数的敏感性:60.00%;特异性:71.43%)。MTV60和TLG40-50可预测原发肿瘤的病理分期1(pT1)(分别为p = 0.0328、0.0240、0.0147)。最佳阈值分别为7.795、99.55和77.58(敏感性分别为:38.46%、53.85%和53.85%;特异性分别为:88.64%、79.55%和81.82%)。SUVmax和SUVmean40-50-60是区分子宫内膜样与非子宫内膜样亚型的唯一参数。SUVmax和SUVmean 50-

相似文献

1
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer.18F-FDG PET衍生参数在子宫内膜癌术前分期中的预后作用
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Jan-Feb;38(1):3-9. doi: 10.1016/j.remn.2018.06.007. Epub 2018 Dec 17.
2
Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.¹⁸F-FDG PET/CT 代谢肿瘤体积和总肿瘤糖酵解与子宫内膜癌淋巴结转移及危险分层的预后价值。
J Gynecol Oncol. 2019 Nov;30(6):e89. doi: 10.3802/jgo.2019.30.e89.
3
Retrospective analysis of the F-FDG PET/CT cutoff value for metabolic parameters was performed as a prediction model to evaluate risk factors for endometrial cancer.回顾性分析 F-FDG PET/CT 代谢参数的截断值,作为评估子宫内膜癌危险因素的预测模型。
Radiat Oncol. 2023 Dec 4;18(1):196. doi: 10.1186/s13014-023-02382-6.
4
Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.使用术前18F-FDG PET/CT测量的代谢肿瘤体积和总病灶糖酵解可预测子宫内膜癌的复发。
BJOG. 2014 Aug;121(9):1097-106; discussion 1106. doi: 10.1111/1471-0528.12543. Epub 2014 Jan 8.
5
Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.18F-FDG PET/CT 代谢肿瘤体积有助于术前识别高危型子宫内膜癌患者。
J Nucl Med. 2015 Aug;56(8):1191-8. doi: 10.2967/jnumed.115.159913. Epub 2015 Jun 4.
6
Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.采用 FDG PET/CT 测量的容积参数在接受立体定向体部放射治疗的 I 期 NSCLC 患者中的应用:预后价值。
Radiology. 2014 Jan;270(1):275-81. doi: 10.1148/radiol.13130652. Epub 2013 Oct 28.
7
A systematic review about the role of preoperative F-FDG PET/CT for prognosis and risk stratification in patients with endometrial cancer.一项关于术前F-FDG PET/CT在子宫内膜癌患者预后及风险分层中作用的系统评价。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2023 Jan-Feb;42(1):24-32. doi: 10.1016/j.remnie.2021.05.009. Epub 2021 May 28.
8
Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.使用(18)F-FDG PET/CT代谢参数对子宫内膜癌患者进行术前风险分层。
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1268-75. doi: 10.1007/s00259-015-3037-2. Epub 2015 Apr 2.
9
Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.术前FDG-PET/CT代谢和容积参数对可切除胰腺癌患者的预后价值
Medicine (Baltimore). 2016 May;95(19):e3686. doi: 10.1097/MD.0000000000003686.
10
Clinical and prognostic value of F-FDG PET/CT in recurrent endometrial carcinoma.F-FDG PET/CT在复发性子宫内膜癌中的临床及预后价值
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Mar-Apr;38(2):87-93. doi: 10.1016/j.remn.2018.09.005. Epub 2018 Dec 17.

引用本文的文献

1
Molecular Imaging in Endometrial Cancer: A Narrative Review.子宫内膜癌的分子成像:一篇叙述性综述
Cancers (Basel). 2025 Aug 8;17(16):2608. doi: 10.3390/cancers17162608.
2
Retrospective analysis of the F-FDG PET/CT cutoff value for metabolic parameters was performed as a prediction model to evaluate risk factors for endometrial cancer.回顾性分析 F-FDG PET/CT 代谢参数的截断值,作为评估子宫内膜癌危险因素的预测模型。
Radiat Oncol. 2023 Dec 4;18(1):196. doi: 10.1186/s13014-023-02382-6.
3
The Evaluation of Preoperative F-FDG PET/CT in Patients with Endometrial Cancer and the Correlation Between PET Parameters and Postoperative Pathology Results.
子宫内膜癌患者术前F-FDG PET/CT评估及PET参数与术后病理结果的相关性
Mol Imaging Radionucl Ther. 2022 Feb 2;31(1):16-22. doi: 10.4274/mirt.galenos.2021.33154.
4
Predictive Value of Metabolic Parameters Derived From F-FDG PET/CT for Microsatellite Instability in Patients With Colorectal Carcinoma.基于 F-FDG PET/CT 的代谢参数对结直肠癌患者微卫星不稳定性的预测价值。
Front Immunol. 2021 Aug 26;12:724464. doi: 10.3389/fimmu.2021.724464. eCollection 2021.